食管癌根治性放疗后心脏亚结构剂量学参数对心脏毒性的预测价值
研究纳入2010年8月至2016年1月两机构716例接受根治性放疗的2-3期食管癌患者,分为训练组432例和外部验证组284例,提取全心及心脏亚结构剂量体积参数,采用竞争风险和Cox回归分析建模。中位随访93个月,68例(15.7%)发生≥3级心脏事件。基于心脏亚结构的模型对≥3级心脏事件预测准确度良好,但较全心变量未显著提升预测;对≥3级急性冠脉综合征和/或充血性心力衰竭,左前降支或左回旋支变量模型优于全心变量模型。
要点
- 中位随访93个月,68例(15.7%)发生≥3级心脏事件,至首次事件中位时间13.5个月。
- 左心室、左前降支和左回旋支平均剂量变量与≥3级心脏事件显著相关。
- 心脏亚结构模型预测≥3级心脏事件准确度良好,但较全心变量未显著改善预测。
核心结论
- 基于心脏亚结构变量的模型对≥3级心脏事件显示出良好的预测准确度。
- 左前降支和左回旋支变量较全心变量显著改善了≥3级急性冠脉综合征和/或充血性心力衰竭事件的预测。
- 作者认为,应监测左回旋支和左前降支等心脏亚结构的放疗剂量,以帮助减少接受根治性放疗的食管癌患者发生显著心脏事件。
研究设计与样本
- 研究为多中心队列研究,纳入2010年8月至2016年1月两机构716例接受根治性放疗的2-3期食管癌患者。
- 患者分为训练组432例和外部验证组284例。
- 提取全心和心脏亚结构的剂量体积直方图参数,进行竞争风险和Cox回归分析。
- 采用受试者工作特征曲线下面积(AUC)和Brier评分评估模型预测性能。
主要发现
- 中位随访93个月,68例(15.7%)发生≥3级心脏事件,至首次事件中位时间13.5个月。
- 多变量分析显示左心室、左前降支和左回旋支平均剂量变量与≥3级心脏事件显著相关。
- AUC和Brier评分显示,整合这些心脏亚结构变量的模型在训练组和验证组中预测≥3级心脏事件均具有良好预测准确度。
- 与全心变量相比,心脏亚结构变量未显著改善≥3级心脏事件的预测。
- 当结局为≥3级急性冠脉综合征和/或充血性心力衰竭时,基于左前降支或左回旋支变量的模型在训练组和验证组中均优于全心变量模型。
临床怎么用
- 作者认为,应监测左回旋支和左前降支等心脏亚结构的放疗剂量,以帮助减少接受根治性放疗的食管癌患者发生显著心脏事件。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the predictive value of the cardiac substructures (CSs) dosimetric parameters for cardiac toxicity after definitive radiation therapy in locally advanced esophageal cancer. METHODS AND MATERIALS: Between August 2010 and January 2016, 716 patients with stage 2-3 esophageal cancer receiving definitive radiation therapy at 2 institutions were divided into training (n = 432) and external validation (n = 284) cohorts. Dose-volume histogram parameters for the whole heart (WH) and CSs were extracted. Competing risks and Cox regressions analyses were performed. The predictive performance of the models was evaluated using the area under the receiver operating characteristic curve (AUC) and the Brier score. RESULTS: With a median follow-up of 93 months, 68 patients (15.7%) developed grade ≥3 cardiac events (G3+ CEs), with a median of 13.5 months to the first event. Multivariable analysis showed left ventricle, left anterior descending (LAD), and mean left circumflex (LCX) variables were significantly associated with G3+ CEs. The AUCs and Brier scores demonstrated favorable predictive accuracies of the models integrating these CS variables when predicting G3+ CEs in the training and validation cohorts. However, compared with the WH variables, the CS variables did not significantly improve the prediction of G3+ CEs. Nevertheless, when G3+ acute coronary syndrome and/or congestive heart failure (ACS/CHF) CE was the outcome of interest, models based on the LAD or LCX variables were superior to the WH variable models in training and validation cohorts. CONCLUSIONS: Models based on CS variables showed favorable predictive accuracy for G3+ CEs. The LAD and LCX variables significantly improved the prediction of G3+ ACS/CHF events compared with the WH variables. Radiation doses to CSs, such as LCX and LAD, should be monitored to help reduce the occurrence of significant CEs in patients with esophageal cancer undergoing definitive radiation therapy.
引用
- Cai G, Li C, Li J, et al. Cardiac Substructures Dosimetric Predictors for Cardiac Toxicity After Definitive Radiotherapy in Esophageal Cancer. Int J Radiat Oncol Biol Phys. 2022. PMID: 35973623. doi:10.1016/j.ijrobp.2022.08.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。